Shares of Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) traded down 3.4% during trading on Friday . The stock traded as low as $9.18 and last traded at $9.20. 890,929 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 1,878,147 shares. The stock had previously closed at $9.52.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on TDOC shares. Jefferies Financial Group boosted their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the company a "hold" rating in a research report on Tuesday, September 17th. Piper Sandler reaffirmed an "overweight" rating and issued a $13.00 target price (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. Evercore ISI lifted their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft upped their price target on Teladoc Health from $10.00 to $12.00 and gave the company a "hold" rating in a research report on Friday, November 1st. Finally, The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a research note on Friday, November 15th. They issued a "buy" rating and a $14.00 price objective for the company. Fourteen analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $12.24.
Check Out Our Latest Report on TDOC
Teladoc Health Stock Performance
The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The stock has a market cap of $1.64 billion, a PE ratio of -1.65 and a beta of 0.97. The company has a 50 day moving average of $9.89 and a two-hundred day moving average of $9.05.
Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10. The firm had revenue of $640.51 million during the quarter, compared to analysts' expectations of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.
Insider Activity at Teladoc Health
In related news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares of the company's stock, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.95% of the company's stock.
Institutional Investors Weigh In On Teladoc Health
Several institutional investors and hedge funds have recently modified their holdings of TDOC. Point72 Asset Management L.P. increased its holdings in shares of Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider's stock valued at $76,803,000 after acquiring an additional 3,063,172 shares during the last quarter. Rubric Capital Management LP acquired a new stake in Teladoc Health during the second quarter valued at approximately $45,267,000. Clearline Capital LP grew its holdings in shares of Teladoc Health by 395.6% in the 2nd quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider's stock worth $42,682,000 after acquiring an additional 3,483,665 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after buying an additional 56,864 shares during the period. Finally, Assenagon Asset Management S.A. acquired a new stake in Teladoc Health during the 3rd quarter valued at $15,801,000. Hedge funds and other institutional investors own 76.82% of the company's stock.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Articles
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
